Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2008

Published online before print December 11, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0907618v1
83/3/785    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buchweitz, J. P.
Right arrow Articles by Kaminski, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchweitz, J. P.
Right arrow Articles by Kaminski, N. E.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0907618


Received for publication September 11, 2007.
Revised November 2, 2007.
Accepted for publication November 6, 2007.


Article

Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of {Delta}9-tetrahydrocannabinol

John P. Buchweitz *{dagger}, Peer W. F. Karmaus {dagger}, Kurt J. Williams {ddagger}, Jack R. Harkema {dagger}{ddagger}, and Norbert E. Kaminski *{dagger}@

Departments of *Pharmacology and Toxicology and {ddagger}Pathobiology and Diagnostic Investigation and {dagger}Center for Integrative Toxicology, Michigan State University, East Lansing, Michigan, USA

@ To whom correspondence should be addressed. E-mail: kamins11{at}msu.edu.


   Abstract

We have previously reported that {Delta}-9-tetrahydrocannabinol ({Delta}9-THC)-treated mice challenged with influenza virus A/PR/8/34 (PR8) developed increased viral hemagglutinin 1 (H1) mRNA levels and decreased macrophage and lymphocyte recruitment to the pulmonary airways when compared with mice challenged with PR8 alone. The objective of the present study was to examine the role of cannabinoid (CB1/CB2) receptors in mediating the effects of {Delta}9-THC on immune and epithelial cell responses to PR8. In the current study, {Delta}9-THC-treated CB1/CB2 receptor null (CB1-/-/CB2-/-) and wild-type mice infected with PR8 had marked increases in viral H1 mRNA when compared with CB1-/-/CB2-/- and wild-type mice challenged with PR8 alone. However, the magnitude of the H1 mRNA levels was greatly reduced in CB1-/-/CB2-/- mice as compared with wild-type mice. In addition, {Delta}9-THC-treated CB1-/-/CB2-/- mice infected with PR8 had increased CD4+ T cells and IFN-{gamma} in bronchoalveolar lavage fluid with greater pulmonary inflammation when compared with {Delta}9-THC-treated wild-type mice infected with PR8. {Delta}9-THC treatment of CB1-/-/CB2-/- mice in the presence or absence of PR8 challenge also developed greater amounts of mucous cell metaplasia in the affected bronchiolar epithelium. Collectively, the immune and airway epithelial cell responses to PR8 challenge in {Delta}9-THC-treated CB1-/-/CB2-/- and wild-type mice indicated the involvement of CB1/CB2 receptor-dependent and -independent mechanisms.

Key Words: mice • lung • influenza • inflammation




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. E. B. Springs, P. W. F. Karmaus, R. B. Crawford, B. L. F. Kaplan, and N. E. Kaminski
Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by {Delta}9-tetrahydrocannabinol
J. Leukoc. Biol., December 1, 2008; 84(6): 1574 - 1584.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.